152 related articles for article (PubMed ID: 23541745)
21. How does the quality of phospholipidosis data influence the predictivity of structural alerts?
Przybylak KR; Alzahrani AR; Cronin MT
J Chem Inf Model; 2014 Aug; 54(8):2224-32. PubMed ID: 25062434
[TBL] [Abstract][Full Text] [Related]
22. In silico toxicology for the pharmaceutical sciences.
Valerio LG
Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
[TBL] [Abstract][Full Text] [Related]
23. Chromatography approaches for early screening of the phospholipidosis-inducing potential of pharmaceuticals.
Jiang Z; Reilly J
J Pharm Biomed Anal; 2012 Mar; 61():184-90. PubMed ID: 22200505
[TBL] [Abstract][Full Text] [Related]
24. In silico prediction of harmful effects triggered by drugs and chemicals.
Vedani A; Dobler M; Lill MA
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):398-407. PubMed ID: 16045954
[TBL] [Abstract][Full Text] [Related]
25. Using entropy of drug and protein graphs to predict FDA drug-target network: theoretic-experimental study of MAO inhibitors and hemoglobin peptides from Fasciola hepatica.
Prado-Prado F; García-Mera X; Abeijón P; Alonso N; Caamaño O; Yáñez M; Gárate T; Mezo M; González-Warleta M; Muiño L; Ubeira FM; González-Díaz H
Eur J Med Chem; 2011 Apr; 46(4):1074-94. PubMed ID: 21315497
[TBL] [Abstract][Full Text] [Related]
26. In silico predictive toxicology: the state-of-the-art and strategies to predict human health effects.
Helma C
Curr Opin Drug Discov Devel; 2005 Jan; 8(1):27-31. PubMed ID: 15679168
[TBL] [Abstract][Full Text] [Related]
27. Three new consensus QSAR models for the prediction of Ames genotoxicity.
Votano JR; Parham M; Hall LH; Kier LB; Oloff S; Tropsha A; Xie Q; Tong W
Mutagenesis; 2004 Sep; 19(5):365-77. PubMed ID: 15388809
[TBL] [Abstract][Full Text] [Related]
28. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
[TBL] [Abstract][Full Text] [Related]
29. Predicting human liver microsomal stability with machine learning techniques.
Sakiyama Y; Yuki H; Moriya T; Hattori K; Suzuki M; Shimada K; Honma T
J Mol Graph Model; 2008 Feb; 26(6):907-15. PubMed ID: 17683964
[TBL] [Abstract][Full Text] [Related]
30. Predicting ADME properties and side effects: the BioPrint approach.
Krejsa CM; Horvath D; Rogalski SL; Penzotti JE; Mao B; Barbosa F; Migeon JC
Curr Opin Drug Discov Devel; 2003 Jul; 6(4):470-80. PubMed ID: 12951810
[TBL] [Abstract][Full Text] [Related]
31. Predictive computational toxicology to support drug safety assessment.
Valerio LG
Methods Mol Biol; 2013; 930():341-54. PubMed ID: 23086849
[TBL] [Abstract][Full Text] [Related]
32. Comparison of MC4PC and MDL-QSAR rodent carcinogenicity predictions and the enhancement of predictive performance by combining QSAR models.
Contrera JF; Kruhlak NL; Matthews EJ; Benz RD
Regul Toxicol Pharmacol; 2007 Dec; 49(3):172-82. PubMed ID: 17703860
[TBL] [Abstract][Full Text] [Related]
33. Cell-based fluorescence assay for evaluation of new-drugs potential for phospholipidosis in an early stage of drug development.
Fujimura H; Dekura E; Kurabe M; Shimazu N; Koitabashi M; Toriumi W
Exp Toxicol Pathol; 2007 Aug; 58(6):375-82. PubMed ID: 17408938
[TBL] [Abstract][Full Text] [Related]
34. A novel in silico approach to drug discovery via computational intelligence.
Hecht D; Fogel GB
J Chem Inf Model; 2009 Apr; 49(4):1105-21. PubMed ID: 19348414
[TBL] [Abstract][Full Text] [Related]
35. NL MIND-BEST: a web server for ligands and proteins discovery--theoretic-experimental study of proteins of Giardia lamblia and new compounds active against Plasmodium falciparum.
González-Díaz H; Prado-Prado F; Sobarzo-Sánchez E; Haddad M; Maurel Chevalley S; Valentin A; Quetin-Leclercq J; Dea-Ayuela MA; Teresa Gomez-Muños M; Munteanu CR; José Torres-Labandeira J; García-Mera X; Tapia RA; Ubeira FM
J Theor Biol; 2011 May; 276(1):229-49. PubMed ID: 21277861
[TBL] [Abstract][Full Text] [Related]
36. Methods for building quantitative structure-activity relationship (QSAR) descriptors and predictive models for computer-aided design of antimicrobial peptides.
Taboureau O
Methods Mol Biol; 2010; 618():77-86. PubMed ID: 20094859
[TBL] [Abstract][Full Text] [Related]
37. Predicting the Risk of Phospholipidosis with in Silico Models and an Image-Based in Vitro Screen.
Fusani L; Brown M; Chen H; Ahlberg E; Noeske T
Mol Pharm; 2017 Dec; 14(12):4346-4352. PubMed ID: 29077420
[TBL] [Abstract][Full Text] [Related]
38. Predicting phospholipidosis using machine learning.
Lowe R; Glen RC; Mitchell JB
Mol Pharm; 2010 Oct; 7(5):1708-14. PubMed ID: 20799726
[TBL] [Abstract][Full Text] [Related]
39. Hydrophilic interaction chromatography with a focus on the drug-phosphate interaction in drug screening to determine the phospholipidosis induction risk.
Okamoto H; Hamaguchi R; Kuroda Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Apr; 1051():33-40. PubMed ID: 28285021
[TBL] [Abstract][Full Text] [Related]
40. Structure-based quantitative structure--activity relationship modeling of estrogen receptor β-ligands.
Dong X; Hilliard SG; Zheng W
Future Med Chem; 2011 Jun; 3(8):933-45. PubMed ID: 21707397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]